IOL Chemicals and Pharmaceuticals Limited NSE Symbol:IOLCP, BSE Security Code:524164 has declared its 3rd(third) quarter audited standalone financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.
Revenue Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
520.82 |
537.96 |
515.21 |
1524.69 |
1463.68 |
Calculated Revenue of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
Change |
Change % |
Change |
Change % |
Change |
Change % |
17.14 |
3.19%(Revenue Decrease) |
5.61 |
1.09%(Revenue Increase) |
61.01 |
4.17%(Revenue Increase) |
Revenue: IOL Chemicals and Pharmaceuticals Limited's financial report shows that the company's revenue decreased by 3.19% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue decrease of Rs.17.14 crores, as the company posted revenue of Rs.520.82 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.537.96 crores.
The result also shows that the company's revenue increased by 1.09% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.5.61 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.515.21 crores.
The company also reported that its revenue increased by 4.17% in 9 months end(April, 2020 - December, 2020) for revenue increase of Rs.61.01 crores, since the company reported revenue of Rs.1524.69 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.1463.68 crores.
Gross Margin(%) Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
42.88 |
37.91 |
47.24 |
41.62 |
46.92 |
Calculated Gross Margin(%) of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
Change |
Change % |
Change |
Change % |
Change |
Change % |
4.97 |
13.12%(GM Increase) |
4.36 |
9.23%(GM Decrease) |
5.30 |
11.30%(GM Decrease) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 13.12% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 4.97% GM increase, as the company reported 42.88% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 37.91% GM.
The result also indicates, the company's GM decreased by 9.23% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 4.36% GM decrease; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 47.24% GM.
The company also reported that its GM decreased by 11.30% in 9 months end(April, 2020 - December, 2020) for 5.30% GM decrease, since the company reported 41.62% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 46.92% GM.
EBITDA Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
165.06 |
175.78 |
163.46 |
498.76 |
447.70 |
Calculated EBITDA of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
Change |
Change % |
Change |
Change % |
Change |
Change % |
10.72 |
6.10%(EBITDA Decrease) |
1.60 |
0.98%(EBITDA Increase) |
51.06 |
11.40%(EBITDA Increase) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 6.10% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA decrease of Rs.10.72 crores, as the company posted EBITDA of Rs.165.06 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.175.78 crores.
The result also shows that the company's EBITDA increased by 0.98% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.1.60 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.163.46 crores.
The company also reported that its EBITDA increased by 11.40% in 9 months end(April, 2020 - December, 2020) for EBITDA increase of Rs.51.06 crores, since the company reported EBITDA of Rs.498.76 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EBITDA of Rs.447.70 crores.
Profit and Loss Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
114.81(Profit ) |
126.96(Profit ) |
98.01(Profit ) |
369.31(Profit ) |
271.03(Profit ) |
Calculated Profit and Loss of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
Change |
Change % |
Change |
Change % |
Change |
Change % |
12.15 |
9.57%(Profit Decrease) |
16.80 |
17.14%(Profit Increase) |
98.28 |
36.26%(Profit Increase) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 9.57% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit decrease of Rs.12.15 crores, as the company posted profit of Rs.114.81 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.126.96 crores.
The result also shows that the company's profit increased by 17.14% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.16.80 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.98.01 crores.
The company also reported that its profit increased by 36.26% in 9 months end(April, 2020 - December, 2020) for profit increase of Rs.98.28 crores, since the company reported profit of Rs.369.31 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted profit of Rs.271.03 crores.
EPS Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
19.54 |
21.61 |
17.22 |
63.45 |
47.64 |
Calculated EPS of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21 |
Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
Change |
Change % |
Change |
Change % |
Change |
Change % |
2.07 |
9.58%(EPS Decrease) |
2.32 |
13.47%(EPS Increase) |
15.81 |
33.19%(EPS Increase) |
EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 9.58% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS decrease of Rs.2.07, as the company posted EPS of Rs.19.54; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.21.61.
The result also shows that the company's EPS increased by 13.47% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.2.32; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.17.22.
The company also reported that its EPS increased by 33.19% in 9 months end(April, 2020 - December, 2020) for EPS increase of Rs.15.81, since the company reported EPS of Rs.63.45; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EPS of Rs.47.64.
***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Add new comment